IMO the main benefit of knocking down the protective pathway would be to prove that you have identified it correctly.
Anyway, even if it hasn't been correctly identified, provided that the clinical trial demonstrates CPACS, all will be well.
- Forums
- ASX - By Stock
- RAC
- Cardioprotection thread
RAC
race oncology ltd
Add to My Watchlist
2.08%
!
$1.18

Cardioprotection thread, page-1168
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.18 |
Change
-0.025(2.08%) |
Mkt cap ! $205.8M |
Open | High | Low | Value | Volume |
$1.22 | $1.22 | $1.17 | $130.6K | 109.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10250 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.21 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 1.165 |
2 | 10250 | 1.150 |
3 | 7910 | 1.130 |
1 | 800 | 1.115 |
4 | 19650 | 1.110 |
Price($) | Vol. | No. |
---|---|---|
1.210 | 2000 | 1 |
1.220 | 7686 | 3 |
1.230 | 2605 | 2 |
1.250 | 4319 | 2 |
1.280 | 4060 | 1 |
Last trade - 15.58pm 30/06/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |